Annual Revenue:
$423.24M+$152.98M(+56.60%)Summary
- As of today, KNSA annual revenue is $423.24 million, with the most recent change of +$152.98 million (+56.60%) on December 31, 2024.
- During the last 3 years, KNSA annual revenue has risen by +$384.69 million (+998.07%).
- KNSA annual revenue is now at all-time high.
Performance
KNSA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$156.80M+$19.01M(+13.80%)Summary
- As of today, KNSA quarterly revenue is $156.80 million, with the most recent change of +$19.01 million (+13.80%) on June 30, 2025.
- Over the past year, KNSA quarterly revenue has increased by +$48.17 million (+44.34%).
- KNSA quarterly revenue is now at all-time high.
Performance
KNSA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$529.33M+$48.17M(+10.01%)Summary
- As of today, KNSA TTM revenue is $529.33 million, with the most recent change of +$48.17 million (+10.01%) on June 30, 2025.
- Over the past year, KNSA TTM revenue has increased by +$190.40 million (+56.18%).
- KNSA TTM revenue is now at all-time high.
Performance
KNSA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
KNSA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +56.6% | +44.3% | +56.2% |
| 3Y3 Years | +998.1% | +481.3% | +488.1% |
| 5Y5 Years | +100.0% | +100.0% | +100.0% |
KNSA Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +998.1% | at high | +224.3% | at high | +199.0% |
| 5Y | 5-Year | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
KNSA Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $156.80M(+13.8%) | $529.33M(+10.0%) |
| Mar 2025 | - | $137.78M(+12.4%) | $481.17M(+13.7%) |
| Dec 2024 | $423.24M(+56.6%) | $122.54M(+9.2%) | $423.24M(+10.2%) |
| Sep 2024 | - | $112.21M(+3.3%) | $384.10M(+13.3%) |
| Jun 2024 | - | $108.63M(+36.0%) | $338.93M(+12.3%) |
| Mar 2024 | - | $79.86M(-4.2%) | $301.77M(+11.7%) |
| Dec 2023 | $270.26M(+22.7%) | $83.39M(+24.4%) | $270.26M(+8.6%) |
| Sep 2023 | - | $67.05M(-6.2%) | $248.75M(-11.4%) |
| Jun 2023 | - | $71.47M(+47.8%) | $280.84M(+18.8%) |
| Mar 2023 | - | $48.34M(-21.9%) | $236.34M(+7.3%) |
| Dec 2022 | $220.18M(+471.2%) | $61.88M(-37.6%) | $220.18M(+24.4%) |
| Sep 2022 | - | $99.14M(+267.5%) | $177.04M(+96.7%) |
| Jun 2022 | - | $26.97M(-16.2%) | $90.00M(+27.2%) |
| Mar 2022 | - | $32.19M(+71.7%) | $70.73M(+83.5%) |
| Dec 2021 | $38.54M | $18.75M(+55.0%) | $38.54M(+94.7%) |
| Sep 2021 | - | $12.10M(+57.0%) | $19.80M(+157.0%) |
| Jun 2021 | - | $7.70M(>+9900.0%) | $7.70M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | $0.00 | - | - |
FAQ
- What is Kiniksa Pharmaceuticals International, plc annual revenue?
- What is the all-time high annual revenue for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc annual revenue year-on-year change?
- What is Kiniksa Pharmaceuticals International, plc quarterly revenue?
- What is the all-time high quarterly revenue for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc quarterly revenue year-on-year change?
- What is Kiniksa Pharmaceuticals International, plc TTM revenue?
- What is the all-time high TTM revenue for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc TTM revenue year-on-year change?
What is Kiniksa Pharmaceuticals International, plc annual revenue?
The current annual revenue of KNSA is $423.24M
What is the all-time high annual revenue for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high annual revenue is $423.24M
What is Kiniksa Pharmaceuticals International, plc annual revenue year-on-year change?
Over the past year, KNSA annual revenue has changed by +$152.98M (+56.60%)
What is Kiniksa Pharmaceuticals International, plc quarterly revenue?
The current quarterly revenue of KNSA is $156.80M
What is the all-time high quarterly revenue for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high quarterly revenue is $156.80M
What is Kiniksa Pharmaceuticals International, plc quarterly revenue year-on-year change?
Over the past year, KNSA quarterly revenue has changed by +$48.17M (+44.34%)
What is Kiniksa Pharmaceuticals International, plc TTM revenue?
The current TTM revenue of KNSA is $529.33M
What is the all-time high TTM revenue for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high TTM revenue is $529.33M
What is Kiniksa Pharmaceuticals International, plc TTM revenue year-on-year change?
Over the past year, KNSA TTM revenue has changed by +$190.40M (+56.18%)